The role of the NGAL biomarker in the assessment of early and prediction of late graft function in kidney transplantation from a living related donor
DOI:
https://doi.org/10.14739/2310-1210.2022.2.243406Keywords:
NGAL, neutrophil gelatinase-associated lipocalin, lipocalin 2, delayed graft function, DGF, kidney transplantationAbstract
The aim. To study the role of NGAL in assessing the recovery of early graft function (GF) and in predicting GF in the first year after kidney transplantation (KT) from a living-related donor (LRD).
Materials and methods. For this aim, a total of 60 kidney recipients who underwent KT from LRDs were examined. To study the early GF, NGAL concentrations in urine samples were measured on days 1, 2, 3, 7 after KT. To study the late GF, the glomerular filtration rate (GFR) was calculated at 3, 6, 12 months after KT. To study the prognosis of GF during the first year after KT, the relationship between u-NGAL and GFR levels at 3, 6, 12 months after KT was analyzed. The incidence of acute kidney transplant rejection (AKTR), delay of graft function (DGF), primary non-function was recorded.
Results. DGF was observed in 5 (8.33 %) recipients with statistically significantly increased mean NGAL levels (P < 0.05) on days 1, 2, 3, 7 as compared to those in normal GF. AKTR was detected in 10 (16.67 %) recipients with statistically significantly increased mean NGAL levels (P < 0.05) on days 1, 2, 3, 7 compared to those in normal GF. Primary allograft non-function was diagnosed in 8 (13.33 %) recipients with statistically significantly increased mean NGAL levels (P < 0.05) on days 1, 2, 3, 7 compared to those in normal GF. Assessing the relationship between NGAL levels on days 1, 2, 3, 7 and GFR at 3, 6, 12 months after transplantation, it was found that GFR was higher in recipients with NGAL levels on days 1, 2, 3, 7 after transplantation within the reference values (<131.7 ng/ml) than that in recipients with NGAL levels on days 1, 2, 3, 7 after transplantation above 131.7 ng/ml.
Conclusions. Evaluation of NGAL after KT informs about the restoration of renal function (rapid decrease in NGAL) or the development of complications (DGF, primary allograft non-function, AKTR) with slow decrease or increase in NGAL levels. Thus, u-NGAL is an early, non-invasive and accurate predictor of the need for dialysis in the first week after KT and the restoration of GF within 12 months.
References
Kielar, M., Dumnicka, P., Gala-Błądzińska, A., Będkowska-Prokop, A., Ignacak, E., Maziarz, B., Ceranowicz, P., & Kuśnierz-Cabala, B. (2020). Urinary NGAL Measured after the First Year Post Kidney Transplantation Predicts Changes in Glomerular Filtration over One-Year Follow-Up. Journal of Clinical Medicine, 10(1), Article 43. https://doi.org/10.3390/jcm10010043
Devarajan, P. (2010). Review: Neutrophil gelatinase-associated lipocalin: A troponin-like biomarker for human acute kidney injury. Nephrology, 15(4), 419-428. https://doi.org/10.1111/j.1440-1797.2010.01317.x
Cappuccilli, M., Capelli, I., Comai, G., Cianciolo, G., & La Manna, G. (2018). Neutrophil Gelatinase-Associated Lipocalin as a Biomarker of Allograft Function After Renal Transplantation: Evaluation of the Current Status and Future Insights. Artificial Organs, 42(1), 8-14. https://doi.org/10.1111/aor.13039
Li, Y. M., Li, Y., Yan, L., Wang, H., Wu, X. J., Tang, J. T., Wang, L. L., & Shi, Y. Y. (2019). Comparison of urine and blood NGAL for early prediction of delayed graft function in adult kidney transplant recipients: a meta-analysis of observational studies. BMC Nephrology, 20(1), Article 291. https://doi.org/10.1186/s12882-019-1491-y
Ramirez-Sandoval, J. C., Herrington, W., & Morales-Buenrostro, L. E. (2015). Neutrophil gelatinase-associated lipocalin in kidney transplantation: A review. Transplantation Reviews, 29(3), 139-144. https://doi.org/10.1016/j.trre.2015.04.004
Qurashi, S., Ghamdi, G., Jaradat, M., Tamim, H., Aljumah, A., Tamimi, W., Al Dawood, A., Binsalih, S., & Al Sayyari, A. (2014). Urinary Neutrophil Gelatinase-Associated Lipocalin and the Occurrence of Delayed Graft Function After Kidney Transplant. Experimental and Clinical Transplantation, 12(5), 396-400. https://doi.org/10.6002/ect.2013.0300
Cheungpasitporn, W., Khoury, N. J., Thongprayoon, C., & Craici, I. M. (2019). Is Remote Ischemic Conditioning of Benefit to Patients Undergoing Kidney Transplantation? Journal of Investigative Surgery, 32(1), 72-74. https://doi.org/10.1080/08941939.2017.1380090
Wu, J., Feng, X., Huang, H., Shou, Z., Zhang, X., Wang, R., Chen, Y., & Chen, J. (2014). Remote ischemic conditioning enhanced the early recovery of renal function in recipients after kidney transplantation: a randomized controlled trial. Journal of Surgical Research, 188(1), 303-308. https://doi.org/10.1016/j.jss.2013.06.058
Veighey, K. V., Nicholas, J. M., Clayton, T., Knight, R., Robertson, S., Dalton, N., Harber, M., Watson, C., De Fijter, J. W., Loukogeorgakis, S., & MacAllister, R. (2019). Early remote ischaemic preconditioning leads to sustained improvement in allograft function after live donor kidney transplantation: long-term outcomes in the REnal Protection Against Ischaemia - Reperfusion in transplantation (REPAIR) randomised trial. British Journal of Anaesthesia, 123(5), 584-591. https://doi.org/10.1016/j.bja.2019.07.019
Mohnen, S. M., van Oosten, M., Los, J., Leegte, M., Jager, K. J., Hemmelder, M. H., Logtenberg, S., Stel, V. S., Hakkaart-van Roijen, L., & de Wit, G. A. (2019). Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data. PLOS ONE, 14(8), Article e0220800. https://doi.org/10.1371/journal.pone.0220800
Perović, S., & Janković, S. (2009). Renal transplantation vs hemodialysis: Cost-effectiveness analysis. Vojnosanitetski pregled, 66(8), 639-644. https://doi.org/10.2298/vsp0908639p
Arze Aimaretti, L., & Arze, S. (2016). Preemptive Renal Transplantation-The Best Treatment Option for Terminal Chronic Renal Failure. Transplantation Proceedings, 48(2), 609-611. https://doi.org/10.1016/j.transproceed.2016.02.047
Yan, L., Borregaard, N., Kjeldsen, L., & Moses, M. A. (2001). The High Molecular Weight Urinary Matrix Metalloproteinase (MMP) Activity Is a Complex of Gelatinase B/MMP-9 and Neutrophil Gelatinase-associated Lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. Journal of Biological Chemistry, 276(40), 37258-37265. https://doi.org/10.1074/jbc.M106089200
Pöge, U., Gerhardt, T., Stoffel-Wagner, B., Palmedo, H., Klehr, H. U., Sauerbruch, T., & Woitas, R. P. (2006). Prediction of glomerular filtration rate in renal transplant recipients: cystatin C or modification of diet in renal disease equation? Clinical Transplantation, 20(2), 200-205. https://doi.org/10.1111/j.1399-0012.2005.00466.x
Murry, C. E., Jennings, R. B., & Reimer, K. A. (1986). Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 74(5), 1124-1136. https://doi.org/10.1161/01.cir.74.5.1124
Wang, Y., Jia, Y., Wang, C., Gao, X., Liu, Y., & Yue, B. (2020). Urinary neutrophil gelatinase-associated lipocalin rapidly decreases in the first week after kidney transplantation. Journal of Clinical Laboratory Analysis, 34(10), Article e23445. https://doi.org/10.1002/jcla.23445
Mishra, J., Ma, Q., Prada, A., Mitsnefes, M., Zahedi, K., Yang, J., Barasch, J., & Devarajan, P. (2003). Identification of Neutrophil Gelatinase-Associated Lipocalin as a Novel Early Urinary Biomarker for Ischemic Renal Injury. Journal of the American Society of Nephrology, 14(10), 2534-2543. https://doi.org/10.1097/01.asn.0000088027.54400.c6
Hall, I. E., Yarlagadda, S. G., Coca, S. G., Wang, Z., Doshi, M., Devarajan, P., Han, W. K., Marcus, R. J., & Parikh, C. R. (2010). IL-18 and Urinary NGAL Predict Dialysis and Graft Recovery after Kidney Transplantation. Journal of the American Society of Nephrology, 21(1), 189-197. https://doi.org/10.1681/ASN.2009030264
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)